Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. (2020)

First Author: Bachoud-Lévi AC
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/mds.28201

PubMed Identifier: 32666599

Publication URI: http://europepmc.org/abstract/MED/32666599

Type: Journal Article/Review

Volume: 35

Parent Publication: Movement disorders : official journal of the Movement Disorder Society

Issue: 8

ISSN: 0885-3185